The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease

The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease

Abstract Background The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer’s disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnes...

Full description

Bibliographic Details
Main Authors: Chih-Sung Liang, Kuan-Pin Su, Chia-Lin Tsai, Jiunn-Tay Lee, Che-Sheng Chu, Ta-Chuan Yeh, Ming-Wei Su, Guan-Yu Lin, Yu-Kai Lin, Hsuan-Te Chu, Chia-Kuang Tsai, Fu-Chi Yang
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Alzheimer’s Research & Therapy
Subjects:
Cytokine
Interleukin-33
Alzheimer’s disease
Mild cognitive disorder
Cognitive decline
Online Access:http://link.springer.com/article/10.1186/s13195-020-00652-z

Internet

http://link.springer.com/article/10.1186/s13195-020-00652-z

Similar Items